Biomarkers market is expected to reach USD 67.33 billion by 2023
However, the requirement of high investment, improper reimbursement policies, poor regulatory bodies, the high cost of testing procedures, and difficulties in sample collection & storage are the major factors restraining the growth of global biomarkers ma
(EMAILWIRE.COM, August 03, 2018 ) Biomarkers are described as the biological molecules or genes assist in crucial clinical decisions and diagnosis of health conditions in patients. These are also known as molecular markers or signature molecules and used to analyze the pharmacologic responses, biological & pathological conditions. Biomarkers are found extensively in body fluids and tissues. Biomarkers are helpful in drug discovery and development processes and assessment of disease conditions.
Biomarkers market is expected to reach USD 67.33 billion by 2023 from USD 35.84 billion in 2018 growing at a CAGR of 13.44% during the forecast period 2018-2023
Key Points from TOC
Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Consumables
5.1.3 Software
5.1.4 Services Growth Hormone Therapy
Request sample report at https://www.marketdataforecast.com/market-reports/biomarkers-market-192/request-sample
5.2 Type
5.2.1 Introduction
5.2.2 Safety Biomarkers
5.2.3 Efficacy Biomarkers
5.2.4 Validation Biomarkers
5.3 Application
5.3.1 Introduction
5.3.2 Diagnostics Development
5.3.3 Drug Discovery and Development
5.3.4 Personalised Medicine
5.3.5 Disease Risk Assessment
5.3.6 Other Applications
Read more Insights at https://www.marketdataforecast.com/market-reports/global-biomarkers-market-192/
5.4 Disease Indications
5.4.1 Introduction
5.4.2 Cancer
5.4.3 CardiovascularDisorders
5.4.4 Neurological Disorders
5.4.5 Immunological Disorders
5.4.6 Other Diseases
On the basis of the geographical region, the global Biomarkers market is segmented as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America held the major market share of 39.0% of the global biomarkers market in 2015, whereas Asia-Pacific is estimated to grow at the highest CAGR of 16.20% during the forecast period 2018-2023
The key players in global biomarkers industry include Bio-Rad Laboratories (U.S.), Qiagen N.V. (Netherlands), Enzo Biochem (U.S.), PerkinElmer, Inc. (U.S.), Merck & Co, Inc. (U.S.), EKF Diagnostics Holdings plc. (U.S.), Meso Scale Diagnostics, LLC (U.S.), Singulex, Inc. (U.S.), BioSims Technologies (France), Cisbio Bioassays (France), and Signosis, Inc. (U.S.).
Biomarkers market is expected to reach USD 67.33 billion by 2023 from USD 35.84 billion in 2018 growing at a CAGR of 13.44% during the forecast period 2018-2023
Key Points from TOC
Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Consumables
5.1.3 Software
5.1.4 Services Growth Hormone Therapy
Request sample report at https://www.marketdataforecast.com/market-reports/biomarkers-market-192/request-sample
5.2 Type
5.2.1 Introduction
5.2.2 Safety Biomarkers
5.2.3 Efficacy Biomarkers
5.2.4 Validation Biomarkers
5.3 Application
5.3.1 Introduction
5.3.2 Diagnostics Development
5.3.3 Drug Discovery and Development
5.3.4 Personalised Medicine
5.3.5 Disease Risk Assessment
5.3.6 Other Applications
Read more Insights at https://www.marketdataforecast.com/market-reports/global-biomarkers-market-192/
5.4 Disease Indications
5.4.1 Introduction
5.4.2 Cancer
5.4.3 CardiovascularDisorders
5.4.4 Neurological Disorders
5.4.5 Immunological Disorders
5.4.6 Other Diseases
On the basis of the geographical region, the global Biomarkers market is segmented as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America held the major market share of 39.0% of the global biomarkers market in 2015, whereas Asia-Pacific is estimated to grow at the highest CAGR of 16.20% during the forecast period 2018-2023
The key players in global biomarkers industry include Bio-Rad Laboratories (U.S.), Qiagen N.V. (Netherlands), Enzo Biochem (U.S.), PerkinElmer, Inc. (U.S.), Merck & Co, Inc. (U.S.), EKF Diagnostics Holdings plc. (U.S.), Meso Scale Diagnostics, LLC (U.S.), Singulex, Inc. (U.S.), BioSims Technologies (France), Cisbio Bioassays (France), and Signosis, Inc. (U.S.).
Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results